GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Goodwill-to-Asset

LakeShore Biopharma Co (LakeShore Biopharma Co) Goodwill-to-Asset : 0.00 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. LakeShore Biopharma Co's Goodwill for the quarter that ended in Sep. 2023 was $0.00 Mil. LakeShore Biopharma Co's Total Assets for the quarter that ended in Sep. 2023 was $220.79 Mil. Therefore, LakeShore Biopharma Co's Goodwill to Asset Ratio for the quarter that ended in Sep. 2023 was 0.00.


LakeShore Biopharma Co Goodwill-to-Asset Historical Data

The historical data trend for LakeShore Biopharma Co's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Goodwill-to-Asset Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Goodwill-to-Asset
- - -

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Goodwill-to-Asset Get a 7-Day Free Trial - - - - -

Competitive Comparison of LakeShore Biopharma Co's Goodwill-to-Asset

For the Biotechnology subindustry, LakeShore Biopharma Co's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's Goodwill-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Goodwill-to-Asset falls into.



LakeShore Biopharma Co Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

LakeShore Biopharma Co's Goodwill to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Goodwill to Asset (A: Mar. 2023 )=Goodwill/Total Assets
=0/249.569
=0.00

LakeShore Biopharma Co's Goodwill to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Goodwill to Asset (Q: Sep. 2023 )=Goodwill/Total Assets
=0/220.787
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co  (NAS:LSB) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


LakeShore Biopharma Co Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.